
June 15 (Reuters) - Incyte Corp INCY.O:
QIAGEN AND INCYTE ANNOUNCE PRECISION MEDICINE COLLABORATION TO DEVELOP COMPANION DIAGNOSTICS FOR PATIENTS WITH MUTANT CALR-EXPRESSING MYELOPROLIFERATIVE NEOPLASMS (MPNS)
INCYTE CORP - QIAGEN TO CREATE MULTIMODAL PANEL USING NGS TECHNOLOGY
INCYTE CORP - DIAGNOSTIC TO IDENTIFY KEY MUTATIONS IN MPN PATIENTS
INCYTE CORP - QIAGEN TO DEVELOP MULTIMODAL PANEL UNDER AGREEMENT WITH INCYTE
INCYTE CORP - QIAGEN TO SUPPORT REGULATORY SUBMISSIONS IN US, EU, ASIA-PACIFIC